Navigation Links
Malaysian Astronaut to Conduct Cancer Research in Space

Malaysia's first astronaut, involved in a 25 million dollar space programme, will carry out scientific research including a study on the growth of cancer cells in outer space, reports said Wednesday.

The astronaut would conduct research on cells, bacteria and the crystallisation of protein, said Abdul Rahman Abdul Jamal, director of the Molecule Medical Institute at the National University of Malaysia.

"The research is aimed at giving local scientists the opportunity to study, design and conduct experiments in space," Abdul Rahman said, cited by the Bernama news agency.

Zulkeffeli Mat Jusoh, national astronaut programme director, said most Malaysians thought sending a fellow countryman into space was a waste of time and money.

"Worse, many think we will spin a top in space or make milk tea," he was quoted as saying by the Star newspaper.

Russia will send Malaysia's first cosmonaut into space in October 2007 as part of a scientific mission aboard the International Space Station.

The two countries signed a deal to send the cosmonaut into space on board Russia's Soyuz spacecraft during a visit to Malaysia by Russian President Vladimir Putin in August 2003.

It is part of a billion-dollar deal for 18 Sukhoi 30-MKM fighter jets.


'"/>




Page: 1

Related medicine news :

1. Malaysian health minister asks to cut down the intake of sugar
2. Malaysian Indian Baby Suffering from Rare Disease, Pierre Robin Syndrome
3. Former Malaysian Prime Minister Suffers Heart Attack
4. Mosquito-borne Dengue Disease on the Rise in Five Malaysian States
5. Hand-foot-mouth Disease Scare Causes Temporary Shut Down of Malaysian Preschools
6. Heart-felt Plea to Malaysian Hospitals
7. Four Malaysians in Hospital for Bird Flu Checks
8. Five Malaysians in Hospital After Bird Flu Outbreak
9. Fast Food Chains Face Ban from Malaysian Childrens Television
10. Astronauts Spacewalk On The International Space Station – NASA Report
11. Exercise in Space Prevents Kidney Stone Formation in Astronauts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... In just two ... Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone so ... nearly 2,000 consumers (and counting) already backing the campaign. , “We are ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... ) announced their partnership to prep patients for colonoscopy at the HyGIeaCare® Center ... in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by ...
(Date:3/24/2017)... ... 24, 2017 , ... “Finding Christ Through Social Media: Year ... chronicling the writer’s path toward true communion with God. “Finding Christ Through Social ... the creation of published author Lea Michelle Johnson, a follower of Christ, wife ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The ... about real people of God in congregations across the United States. “The ... minister ordained in 1964 who has served congregations in seven states throughout his ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma ... innovative TransCon technology to address significant unmet medical needs ... host a conference call and webcast on Monday, April ... Endocrine Society in Orlando, Florida , ... pipeline candidates (TransCon Growth Hormone, TransCon PTH and TransCon ...
(Date:3/23/2017)... DIEGO , March 23, 2017  A ... fast and accurate identification of individuals who carry ... risk for a rare yet potentially deadly side ... and bipolar disorder.  The gene HLA-B*15:02 ... reactions such as Stevens-Johnson syndrome and toxic epidermal ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
Breaking Medicine Technology: